Clinical Trials Browser

Interventional × Cholangiocarcinoma × futibatinib × Clear all

NCT06506955 2026-03-11

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

Phase 2/3 Enrolling by invitation

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

NCT05727176 2025-12-29

FOENIX-CCA4

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma